CANCER OF PANCREAS
Clinical trials for CANCER OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to help cancer survivors manage other health problems
Disease control OngoingThis study tests a new way for cancer doctors and primary care doctors to work together to help cancer survivors manage other health problems like high blood pressure, diabetes, and high cholesterol. About 800 adults with certain cancers and at least one of these conditions will …
Matched conditions: CANCER OF PANCREAS
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage trial is testing a new drug called HBI-2438 in people with advanced solid tumors (like lung, colorectal, or pancreatic cancer) that have a specific genetic change called KRAS G12C. The main goals are to find the safest dose and understand how the drug moves throu…
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug HBI-2376 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis early-stage trial tests a new oral drug called HBI-2376 in about 42 adults with advanced solid tumors (like lung, colon, or pancreatic cancer) that have KRAS or EGFR mutations and have stopped responding to standard treatments. The main goals are to find a safe dose and unde…
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC